Drupal.behaviors.print = function(context) {window.print();window.close();}>

Alnylam Provides Pipeline Update, Completes Phase I Trial of Liver Cancer Drug

August 04, 2011

Alnylam Provides Pipeline Update, Completes Phase I Trial of Liver Cancer Drug

The company also reported its second-quarter financial results, posting narrowed losses amid decreased costs.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories